Innoviva (INVA) FCF Margin (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8,712.00 |
| Jun 30, 2025 | -1,090.00 |
| Sep 30, 2024 | 10,056.00 |
| Jun 30, 2024 | -379,133.00 |
| Sep 30, 2023 | -373,622.00 |
| Jun 30, 2023 | 67,364.00 |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | -373,973.00 |
| Sep 30, 2021 | -697,312.00 |
| Jun 30, 2021 | -64,561.00 |
| Mar 31, 2021 | -903,067.00 |
| Dec 31, 2020 | 1.68 Mn |
| Sep 30, 2020 | -1,701.00 |
| Jun 30, 2020 | 770.00 |
| Mar 31, 2020 | 533.00 |
| Dec 31, 2019 | 75.00 |
| Sep 30, 2019 | -83.00 |
| Jun 30, 2019 | -5,078.00 |
| Mar 31, 2019 | 6,155.00 |
| Dec 31, 2018 | -2,010.00 |
| Sep 30, 2018 | 2,036.00 |
| Jun 30, 2018 | -1,819.00 |
| Mar 31, 2018 | 2,645.00 |
| Dec 31, 2017 | -2,056.00 |
| Sep 30, 2017 | 5,075.00 |
| Jun 30, 2017 | -2,990.00 |
| Mar 31, 2017 | 2,027.00 |
| Dec 31, 2016 | -1,160.00 |
| Sep 30, 2016 | 2,153.00 |
| Jun 30, 2016 | 836.00 |
| Mar 31, 2016 | -30.00 |
| Dec 31, 2015 | 1,070.00 |
| Sep 30, 2015 | -82.00 |
| Jun 30, 2015 | 4,392.00 |
| Mar 31, 2015 | 4,163.00 |
| Dec 31, 2014 | 204,406.00 |
| Sep 30, 2014 | 360,182.00 |
| Jun 30, 2014 | 98,859.00 |
| Mar 31, 2014 | -391,340.00 |
| Dec 31, 2013 | 722,511.00 |
| Sep 30, 2013 | -869,688.00 |
| Jun 30, 2013 | 113,419.00 |
| Mar 31, 2013 | -246,835.00 |
| Dec 31, 2012 | 198,699.00 |
| Sep 30, 2012 | 473,005.00 |
| Jun 30, 2012 | -666,359.00 |
| Mar 31, 2012 | 45,603.00 |
| Dec 31, 2011 | -18,978.00 |
| Sep 30, 2011 | -39.00 |
| Jun 30, 2011 | 13,118.00 |